ADIM
SNV

Alpha DNA Investment Management’s Synovus SNV Stock Holding History

Alpha DNA Investment Management’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,052
Closed -$603K – 240
2024
Q1 		$603K Buy
+15,052
New +$566K 0.22% 103
2022
Q3 		– Sell
-27,547
Closed -$992K – 195
2022
Q2 		$992K Buy
+27,547
New +$1.14M 0.85% 58

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Alpha DNA Investment Management's SNV Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Synovus (SNV) in Q2 2024, closing a stake of 15,052 shares — an estimated $603K sold.

Alpha DNA Investment Management first reported a position in SNV in Q2 2022 and held it in 2 quarters. The position peaked at $992K in Q2 2022. 382 funds tracked by Wall St. Rank hold SNV as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Synovus position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 15,052 Synovus shares in Q2 2024, an estimated $603K.
  • Alpha DNA Investment Management first reported a position in Synovus in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Synovus position peaked at $992K in Q2 2022.
  • 382 funds tracked by Wall St. Rank held Synovus as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.